Upadacitinib (CAS 1310726-60-3) is a JAK1-selective inhibitor used for the treatment of rheumatoid arthritis, atopic dermatitis, and other inflammatory diseases. It works by blocking the JAK-STAT signaling pathway, which is involved in immune and inflammatory responses.
Upadacitinib
Category:Organic Intermediates
CAS No.:1310726-60-3
Product Grade: Pharma grade
Purity / Assay: 99%
Molecular Formula:C₁₇H₁₉F₃N₆O
Molecular Weight:380.37
Synonym(s):Upadacitinib; ABT-494
Upadacitinib (CAS 1310726-60-3) is a JAK1-selective inhibitor used for the treatment of rheumatoid arthritis, atopic dermatitis, and other inflammatory diseases. It works by blocking the JAK-STAT signaling pathway, which is involved in immune and inflammatory responses.
1. API for rheumatoid arthritis. 2. Treatment of atopic dermatitis. 3. JAK1 inhibitor therapy. 4. Autoimmune disease research.
25kg/drum; 200kg/drum
CAS No.: 1310726-60-3
Product Name: Upadacitinib
Purity / Assay:99%
Molecular Formula:C₁₇H₁₉F₃N₆O
Molecular Weight:380.37
Synonym(s):Upadacitinib; ABT-494
For global customers, we provide complete technical documentation to support product evaluation, regulatory compliance and safe handling during transportation and application.